A biotechnology company focused on developing therapeutics for acute cardiovascular diseases and respiratory conditions. The company's pipeline includes istaroxime for acute decompensated heart failure, AEROSURF for respiratory distress syndrome in premature infants, and several other candidates targeting heart failure, hypertension, and solid tumors.